Additional file 1: of Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer

Table S1. Phase II and III Clinical trials evaluating Atezolizumab in combination with Bevacizumab (DOCX 15 kb)